Navigation Links
The Effect Of Pain Relievers In Treating Kids With Migraine Questioned

Migraine headaches, usually an inherited disorder, are common in children with frequency increasing in adolescence, // according to researchers. The pain relievers ibuprofen and acetaminophen are safe and effective for treating migraine headaches in children and adolescents according to new guidelines published by the American Academy of Neurology and the Child Neurology Society.

Researchers evaluated over 166 articles and abstracts on children ages 3 to 18 to determine the best treatment for migraines in these patients. Results showed acetaminophen and ibuprofen, both over-the-counter pain relievers, are safe and effective to use as a migraine treatment in children and adolescents. The nasal spray sumatriptan was found safe and effective for adolescents to use for migraines. However, the study showed insufficient evidence to recommend preventive treatments such as topiramate, amitriptyline, or divalproex sodium.

Thus researchers say they are confident that pharmacological headache treatments given to adults are also safe and effective for children.
'"/>




Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. Acupuncture May Help Chemotherapy Side Effects
4. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
5. Fluoride Found Effective in Osteoporosis
6. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
7. Implantable Contact Lens Found Safe and Effective
8. Effective And Economical Agent For Anthrax
9. Stem Cell Transplants May Be Effective For MS Patients
10. Chemotherapy Pill Has Fewer Side Effects Than IV
11. Effect of Osteosarcoma predicted by scans
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a weight ... app plans to fix the two major problems leading the fitness industry today:, ... program , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... TX (PRWEB) , ... June 24, 2016 , ... People ... part in Genome magazine’s Code Talker Award, an essay contest in which patients and ... an award to be presented at the 2016 National Society of Genetic Counselors (NSGC) ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 The vast majority ... outpatient dialysis facility.  Treatments are usually 3 times a ... per visit, including travel time, equipment preparation and wait ... but especially grueling for patients who are elderly and ... skilled nursing and rehabilitation centers for some duration of ...
(Date:6/23/2016)... FRANKLIN, Tenn. , June 23, 2016 ... for automating, integrating and transforming the patient ... launch of several innovative new products and ... depth of its revenue cycle offerings. These ... establish more efficient workflows, remain compliant in ...
(Date:6/23/2016)... 2016  The National Pharmaceutical Council (NPC) today ... policy research organization as its newest member.  ... vice president and chief scientific officer, Mallinckrodt Pharmaceuticals, ... NPC Board of Directors. ... joined us in support of our efforts to ...
Breaking Medicine Technology: